Latest Insider Transactions at Bioventus Inc. (BVS)
This section provides a real-time view of insider transactions for Bioventus Inc. (BVS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Bioventus Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Bioventus Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 10
2022
|
Alessandra Pavesio Fmr. SVP & Chief Science Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
191,708
+49.87%
|
-
|
|
Oct 29
2021
|
Stavros G. Vizirgianakis Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,780,923
+50.0%
|
-
|
|
Sep 09
2021
|
Kenneth Michael Reali Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,800
+13.87%
|
$25,200
$14.81 P/Share
|
|
Feb 11
2021
|
Katrina J Church SVP & Chief Compliance Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+50.0%
|
$32,500
$13.0 P/Share
|
|
Feb 11
2021
|
John Nosenzo Fmr. Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
500
+50.0%
|
$6,500
$13.0 P/Share
|
|
Feb 11
2021
|
Kenneth Michael Reali Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
9,375
+50.0%
|
$121,875
$13.0 P/Share
|
|
Feb 11
2021
|
Gregory O. Anglum SVP & CFO |
BUY
Open market or private purchase
|
Direct |
6,000
+50.0%
|
$78,000
$13.0 P/Share
|
|
Feb 11
2021
|
Anthony D'Adamio SVP & General Counsel |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$13,000
$13.0 P/Share
|
|
Feb 11
2021
|
Alessandra Pavesio Fmr. SVP & Chief Science Off. |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$13,000
$13.0 P/Share
|